National Cerebral and Cardiovascular

Menu

  1. National Cerebral and Cardiovascular Center TOP
  2. Hospital
  3. The Group of Treatment
  4. Cardiovascular department - Division of Arrhythmia
  5. 研究・業績

Division of Arrhythmia

研究・業績

論文（過去3年間）

2015年　研究業績

  1. Aiba T, Noda T, Hidaka I, Inagaki M, Katare RG, Ando M, et al. Acetylcholine Suppresses Ventricular Arrhythmias and Improves Conduction and Connexin-43 Properties During Myocardial Ischemia in Isolated Rabbit Hearts. J Cardiovasc Electrophysiol. 2015;26(6):678-85.
  2. Asaumi Y, Noguchi T, Morita Y, Matsuyama TA, Otsuka F, Fujiwara R, et al. Non-contrast T1-weighted magnetic resonance imaging at 3.0 Tesla in a patient undergoing elective percutaneous coronary intervention - clinical and pathological significance of high-intensity plaque. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(1):218-20.
  3. Ishibashi K, Kubo T, Kitabata H, Takarada S, Shimamura K, Tanimoto T, et al. Improvement of Cardiac Function by Increasing Stimulus Strength During Left Ventricular Pacing in Cardiac Resynchronization Therapy. international heart journal. 2015;56.
  4. Itoh H, Dochi K, Shimizu W, Denjoy I, Ohno S, Aiba T, et al. A Common Mutation of Long QT Syndrome Type 1 in Japan. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(9):2026-30.
  5. Kaitani K, Inoue K, Kobori A, Nakazawa Y, Ozawa T, Kurotobi T, et al. Efficacy of Antiarrhythmic Drugs Short-Term Use After Catheter Ablation for Atrial Fibrillation (EAST-AF) trial. Eur Heart J. 2015.
  6. Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, et al. Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome. Eur Heart J. 2015.
  7. Kamakura T, Wada M, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, et al. Evaluation of the Necessity for Cardioverter-Defibrillator Implantation in Elderly Patients With Brugada Syndrome. Circulation Arrhythmia and electrophysiology. 2015;8(4):785-91.
  8. Kaneko Y, Kato, Nakahara S, Tobiume T, Morishima I, Tanaka K, et al. Characteristics and Catheter Ablation of Focal Atrial Tachycardia Originating From the Interatrial Septum. Heart, lung & circulation. 2015;24(10):988-95.
  9. Kishimoto I, Makino H, Ohata Y, Tamanaha T, Tochiya M, Kusano K, et al. Impact of B-type natriuretic peptide (BNP) on development of atrial fibrillation in people with Type 2 diabetes. Diabetic medicine : a journal of the British Diabetic Association. 2015.
  10. Koizumi A, Sasano T, Kimura W, Miyamoto Y, Aiba T, Ishikawa T, et al. Genetic defects in a His-Purkinje system transcription factor, IRX3, cause lethal cardiac arrhythmias. Eur Heart J. 2015.
  11. Makimoto H, Nakajima I, Miyamoto K, Yamada Y, Okamura H, Noda T, et al. Clinical impact of mapping strategies for treatment of ventricular tachycardias in patients with structural heart disease. Pacing and clinical electrophysiology : PACE. 2015;38(5):630-40.
  12. Mishima T, Miyamoto K, Morita Y, Noda T, Aiba T, Kusano K. Visualization of Pulmonary Vein-Left Atrium Lesions Using Delayed-Enhancement Magnetic Resonance Imaging after Cryothermal Balloon Catheter Ablation: A Case Report. HeartRhythm Case Reports. 2015.
  13. Miyamoto K, Aiba T, Arihiro S, Watanabe M, Kokubo Y, Ishibashi K, et al. Impact of renal function deterioration on adverse events during anticoagulation therapy using non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Heart and vessels. 2015.
  14. Miyamoto K, Aiba T, Kimura H, Hayashi H, Ohno S, Yasuoka C, et al. Efficacy and safety of flecainide for ventricular arrhythmias in patients with Andersen-Tawil syndrome with KCNJ2 mutations. Heart rhythm : the official journal of the Heart Rhythm Society. 2015;12(3):596-603.
  15. Miyamoto K, Nakasuka K, Kusano K. Effect of Renal Function on Anticoagulation Therapy in Asian Patients. Circulation Journal. 2015.
  16. Miyamoto K, Noda T, Satomi K, Wada M, Nakajima I, Ishibashi K, et al. Larger low voltage zone in endocardial unipolar map compared with that in epicardial bipolar map indicates difficulty in eliminating ventricular tachycardia by catheter ablation. Heart and vessels. 2015.
  17. Miyazaki A, Sakaguchi H, Kagisaki K, Tsujii N, Matsuoka M, Yamamoto T, et al. Optimal pacing sites for cardiac resynchronization therapy for patients with a systemic right ventricle with or without a rudimentary left ventricle. Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology. 2015.
  18. Nagai T, Nagano N, Sugano Y, Asaumi Y, Aiba T, Kanzaki H, et al. Effect of Corticosteroid Therapy on Long-Term Clinical Outcome and Left Ventricular Function in Patients With Cardiac Sarcoidosis. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(7):1593-600.
  19. Nagano N, Nagai T, Sugano Y, Morita Y, Asaumi Y, Aiba T, et al. Association Between Basal Thinning of Interventricular Septum and Adverse Long-Term Clinical Outcomes in Patients With Cardiac Sarcoidosis. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(7):1601-8.
  20. Noda T. Genome Packaging Mechanism of Influenza A Virus. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 2015;135(9):1011-3.
  21. Noda T, Kikugawa T, Tanji N, Miura N, Asai S, Higashiyama S, et al. Longterm exposure to leptin enhances the growth of prostate cancer cells. International journal of oncology. 2015;46(4):1535-42.
  22. Okamatsu H, Ohara T, Kanzaki H, Nakajima I, Miyamoto K, Okamura H, et al. Impact of Left Ventricular Diastolic Dysfunction on Outcome of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy. Circulation Journal. 2015;79(2):419 - 24.
  23. Okamura H, Kamakura T, Morita H, Tokioka K, Nakajima I, Wada M, et al. Risk Stratification in Patients With Brugada Syndrome Without Previous Cardiac Arrest - Prognostic Value of Combined Risk Factors. Circulation Journal. 2015;79(2):310-+.
  24. Otsuka Y, Okamura H, Sato S, Nakajima I, Ishibashi K, Miyamoto K, et al. Defibrillation lead placement using a transthoracic transatrial approach in a case without transvenous access due to lack of the right superior vena cava. J Arrhythm. 2015;31(3):159-62.
  25. Saito Y, Nakamura K, Yoshida M, Sugiyama H, Ohe T, Kurokawa J, et al. Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker. PloS one. 2015;10(9):e0138193.
  26. Shibata T, Kawakami S, Noguchi T, Tanaka T, Asaumi Y, Kanaya T, et al. Prevalence, Clinical Features, and Prognosis of Acute Myocardial Infarction Attributable to Coronary Artery Embolism. Circulation. 2015;132(4):241-50.
  27. Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, et al. Exome Analyses of Long QT Syndrome Reveal Candidate Pathogenic Mutations in Calmodulin-Interacting Genes. PloS one. 2015;10(7):e0130329.
  28. Takaya Y, Kusano KF, Nakamura K, Ito H. Comparison of outcomes in patients with probable versus definite cardiac sarcoidosis. The American journal of cardiology. 2015;115(9):1293-7.
  29. Takaya Y, Kusano KF, Nakamura K, Ito H. Outcomes in patients with high-degree atrioventricular block as the initial manifestation of cardiac sarcoidosis. The American journal of cardiology. 2015;115(4):505-9.
  30. Wada T, Nagase S, Morita H, Nakagawa K, Nishii N, Nakamura K, et al. Incidence and Clinical Significance of Brugada Syndrome Masked by Complete Right Bundle-Branch Block. Circulation journal : official journal of the Japanese Circulation Society. 2015.
  31. Wada Y, Aiba T, Matsuyama TA, Nakajima I, Ishibashi K, Miyamoto K, et al. Clinical and Pathological Impact of Tissue Fibrosis on Lethal Arrhythmic Events in Hypertrophic Cardiomyopathy Patients With Impaired Systolic Function. Circulation journal : official journal of the Japanese Circulation Society. 2015;79(8):1733-41.
  32. 鎌倉史郎. 心室頻拍. 今日の治療指針2015. 2015:393-4.
  33. 鎌倉史郎. 心房細動患者における心原性脳塞栓症の予防戦略. 西宮市医師会医学雑誌. 2015;20:1-5.
  34. 鎌倉令 草野研吾. 心房細動治療（薬物）ガイドライン2013のポイント. 循環器内科. 2015;78(1):39-46.
  35. 宮本康二. 抗凝固療法の適応と抗凝固薬の使い分け―非ビタミンK阻害経口抗凝固薬を含めて. 循環器内科. 2015;78(1):92-7.
  36. 宮本康二, 廣瀬紗也子. 抗凝固療法の新時代:若手医師の考え方. Medical Tribune 2015年5月14日号（特別企画）. 2015.
  37. 松山高明 岡村英夫. ２.ペースメーカーリードの装着に関して　e.リードの癒着. Heart View. 2015;19(4):98-108.
  38. 川上大志, 里見和浩, 石橋耕平,中島育太郎,宮本康二,山田優子,岡村英夫,野田崇,相庭武司,鎌倉史郎,草野研吾. 発作性心房細動患者における再肺静脈隔離後の再発因子の検討. 心電図. 2015;35(1):15-24.
  39. 相庭 武司. 不整脈の遺伝子診断と治療. Annual Review 2015循環器. 2015:152-62.
  40. 相庭 武司. QT延長症候群の遺伝子診断~遺伝子診断の意義は? 遺伝子型別の症状とは?~. 不整脈症候群. 2015:24-9.
  41. 相庭 武司. 先天性QT延長症候群. 不整脈症候群. 2015:36-9.
  42. 草野研吾. 上室性頻拍・心房粗動. 今日の治療指針2015. 2015:386-8.
  43. 草野研吾. 薬物によるリズムコントロール療法の適応と実際. CARDIAC PLACTICE. 2015;26,No.1:39-44.
  44. 草野研吾. 致死性不整脈の診断と治療. Annual Review 2015循環器. 2015:127-31.
  45. 野田 崇, 和田 有, 鎌倉 令, 和田 暢, 中島 育太郎, 石橋 耕平, et al. Torsades de Pointesの特殊な発症パターンを呈した,たこつぼ型心筋症の1例. 心臓. 2015;47:56-61.
  46. 野田崇, 草野研吾. 不整脈原性右室心筋症の治療の実際~心筋症の進行による影響とは?~. 不整脈症候群. 2015:160-5.
  47. 和田悠子、相庭武司. 高齢者の心房細動診断─見つけるコツ─. 治療　2015年4月 Vol97 No4　高齢者×心房細動 2015.

2014年　研究業績

  1. Kitajima R, Fujino M, Yamane T, Noguchi T, Kusano K, Anzai T, Goto Y, Ishihara M, Yasuda S and Ogawa H. A Case of Syncope and Cardiac Tamponade After Silent Acute Myocardial Infarction Successfully Diagnosed by Multiple Imaging Modalities. Journal of Cardiac Failure. 20, S175, 2014.
  2. Kokunai Y, Nakata T, Furuta M, Sakata S, Kimura H, Aiba T, Yoshinaga M, Osaki Y, Nakamori M, Itoh H, Sato T, Kubota T, Kadota K, Shindo K, Mochizuki H, Shimizu W, Horie M, Okamura Y, Ohno K and Takahashi MP. A Kir3.4 mutation causes Andersen-Tawil syndrome by an inhibitory effect on Kir2.1. Neurology. 82, 1058-1064, 2014.
  3. Aiba T, Farinelli F, Kostecki G, Hesketh GG, Edwards.D, Biswas S, Tung L and Tomaselli GF. A Mutation Causing Brugada Syndrome Identifies a Mechanism for Altered Autonomic and Oxidant Regulation of Cardiac Sodium Currents. Circulation:Cardiovascular Genetics. 7, 249-256, 2014.
  4. Arakawa J, Hamabe A, Aiba T, Nagai T, Yoshida M, Touya T, Ishigami N, Hisadome H, Katsushika S, Tabata H, Miyamoto Y and Shimizu W. A novel cardiac ryanodine receptor gene (RyR2) mutation in an athlete with aborted sudden cardiac death: a case of adult-onset catecholaminergic polymorphic ventricular tachycardia. Heart and Vessels. e-pub, 2014.
  5. Moriyama N, Ishihara M, Noguchi T, Nakanishi M, Arakawa T, Asaumi Y, Kumasaka L, Kanaya T, Miyagi T, Nagai T, Yamane T, Fujino M, Honda S, Fujiwara R, Anzai T, Kusano K, Goto Y, Yasuda S and Ogawa H. Admission Hyperglycemia Is an Independent Predictor of Acute Kidney Injury in Patients With Acute Myocardial Infarction. Circulation Journal. 78, 1475-1480, 2014.
  6. Nakamura T, Inoue Y, Kanzaki H, Morita Y, Nakajima I, Ishibashi K, Miyamoto K, Okamura H, Noda T, Aiba T, Kamakura S, Anzai T, Ishihara M, Yasuda S, Ogawa H and Kusano K. ANTIARRHYTHMIC EFFECT OF INVASIVE TREATMENT IN HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY: SIGNIFICANCE OF SUBSTRATE MODIFICATION DETECTED BY CARDIAC MRI. Journal of the American College of Cardiology. 63, A816, 2014.
  7. Noda T, Kurita T, Nitta T, Abe H, Watanabe S, Furushima H, Matsumoto N, Toyoshima T, Shimizu A, Mitamura H, Ohe T and Aizawa Y. Appropriate Duration of Driving Restrictions After Inappropriate Therapy From Implantable Cardiac Shock Devices - Interim Analysis of the Nippon Storm Study. Circulation Journal. 78, 1989-+, 2014.
  8. Akagi S, Ogawa A, Miyaji K, Kusano K, Ito H and Matsubara H. Catecholamine support at the initiation of epoprostenol therapy in pulmonary arterial hypertension. Annals of the American Thoracic Society. 11, 719-727, 2014.
  9. Kijima Y, Akagi T, Nakagawa K, Taniguchi M, Ueoka A, Deguchi K, Toh N, H Oe., Kusano K, Sano S and Ito H. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: Initial experiences in japan. Cardiovascular Intervention and Therapeutics. 29, 11-17, 2014.
  10. Noda T, Kusano K, Nakajima I, Anzai T, Ishihara M, Yasuda S, Kitakaze M and Ogawa H. Clinical Impact of Cardiac Resynchronization Therapy in Patients with Atrial Fibrillation. Journal of Cardiac Failure. 20, S140, 2014.
  11. Bando S, Soeki T, Matsuura T, Niki T, Ise T, Yamaguchi K, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Aiba T, Shimizu W and Sata M. Congenital long QT syndrome with compound mutations in the KCNH2 gene. Heart and Vessels. 29, 554-559, 2014.
  12. Nagai T, Honda S, Sugano Y, Matsuyama TA, Ohta-Ogo K, Asaumi Y, Ikeda Y, Kusano K, Ishihara M, Yasuda S, Ogawa H, Ishibashi-Ueda H and Anzai T. Decreased Myocardial Dendritic Cells is Associated With Impaired Reparative Fibrosis and Development of Cardiac Rupture After Myocardial Infarction in Humans. Journal of the American Heart Association. 3, 2014.
  13. Nagase S and Kusano KF. Deep-inspiration test. A novel and simple technique of unmasking type 1 ecg in brugada syndrome. Circulation Journal. 78, 311-312, 2014.
  14. Otsuka Y, Okamura H, Sato S, Nakajima I, Ishibashi K, Miyamoto K, Noda T, Aiba T, Kamakura S, Kobayashi J, Yasuda S, Ogawa H and Kusano K. Defibrillation lead placement by transthoracic transatrial approach in a case without transvenous access due to a lack of right superior vena cava. Journal of Arrhythmia. 2014.
  15. Aikawa Y, Noguchi T, Morita Y, Yamada N, Kusano K, Anzai T, Goto Y, Ishihara M, Ogawa H and Yasuda S. Dynamic Study of Myocardial Contrast-enhancement in Takotsubo-cardiomyopathy: Reversible Myocardial Injury Detected by Early Gadolinium Enhancement . Journal of Cardiac Failure. 20, S176, 2014.
  16. Miyamoto K, Aiba T, Nakajima I, Yamada Y, Okamura H, Noda T, Satomi K, Ishihara M, Anzai T, Yasuda S, Ogawa H, Kamakura S and Shimizu W. Efficacy and Safety of Novel Anticoagulant Dabigatran in Clinical Practice for Japanese Patients with Non-valvular Atrial Fibrillation. Journal of Arrhythmia. 30, 58-64, 2014.
  17. Katsuumi G, Shimizu W, Watanabe H, Noda T, Nogami A, Ohkubo K, Makiyama T, Takehara N, Kawamura Y, Hosaka Y, Sato M, Fukae S, Chinushi M, Oda H, Okabe M, Kimura A, Maemura K, Watanabe I, Kamakura S, Horie M, Aizawa Y, Makita N and Minamino T. Efficacy of bepridil to prevent ventricular fibrillation in severe form of early repolarization syndrome. International Journal Of Cardiology. 172, 519-522, 2014.
  18. Kaneko Y, Horie M, Niwano S, Kusano KF, Takatsuki S, Kurita T, Mitsuhashi T, Nakajima T, Irie T, Hasegawa K, Noda T, Kamakura S, Aizawa Y, Yasuoka R, Torigoe K, Suzuki H, Ohe T, Shimizu A, Fukuda K, Kurabayashi M and Aizawa Y. Electrical Storm in Patients With Brugada Syndrome Is Associated With Early Repolarization. Circulation:Arrhythmia and Electrophysiology. 7, 1122-1128, 2014.
  19. Tokioka K, Kusano KF, Morita H, Miura D, Nishii N, Nagase S, Nakamura K, Kohno K, Ito H and Ohe T. Electrocardiographic Parameters and Fatal Arrhythmic Events in Patients With Brugada Syndrome. Journal of the American College of Cardiology. 63, 2131-2138, 2014.
  20. Takaya Y, Noda T, Nakajima I, Yamada Y, Miyamoto K, Okamura H, Satomi K, Aiba T, Kusano KF, Kanzaki H, Anzai T, Ishihara M, Yasuda S, Ogawa H, Kamakura S and Shimizu W. Electrocardiographic Predictors of Response to Cardiac Resynchronization Therapy in Patients With Intraventricular Conduction Delay. Circulation Journal. 78, 71-77, 2014.
  21. Ise T, Hasegawa T, Morita Y, Yamada N, Funada A, Takahama H, Amaki M, Kanzaki H, Okamura H, Kamakura S, Shimizu W, Anzai T and Kitakaze M. Extensive late gadolinium enhancement on cardiovascular magnetic resonance predicts adverse outcomes and lack of improvement in LV function after steroid therapy in cardiac sarcoidosis. Heart. 100, 1165-1172, 2014.
  22. Fujino M, Ishihara M, Honda S, Kawakami S, Yamane T, Nagai T, Nakao K, Kanaya T, Kumasaka L, Asaumi Y, Arakawa T, Tahara Y, Nakanishi M, Noguchi T, Kusano K, Anzai T, Goto Y, Yasuda S and Ogawa H. Impact of Acute and Chronic Hyperglycemia on In-Hospital Outcomes of Patients With Acute Myocardial Infarction. The American Journal of Cardiology. 114, 1789-1793, 2014.
  23. Kinugawa K, Nagai R, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T and Hori M. Impacts of Patient Characteristics on the Effectiveness of Landiolol in AF/AFL Patients Complicated with LV Dysfunction: Subgroup Analysis of the J-Land Study. Advances in Therapy. 31, 426-439, 2014.
  24. Yamada Y, Kinoshita H, Kuwahara K, Nakagawa Y, Kuwabara Y, Minami T, Yamada C, Shibata J, Nakao K, Cho K, Arai Y, Yasuno S, Nishikimi T, Ueshima K, Kamakura S, Nishida M, Kiyonaka S, Mori Y, Kimura T, Kangawa K and Nakao K. Inhibition of N-type Ca2+ channels ameliorates an imbalance in cardiac autonomic nerve activity and prevents lethal arrhythmias in mice with heart failure. Cardiovascular Research. 104, 183-193, 2014.
  25. Kamijima A, Ishibashi K, Wada M, Nakajima I, Miyamoto K, Okamura H, Noda T, Aiba T, Kamakura S and Kusano K. Long-term Prognosis for Ventricular Pacing of Patients with Pacemaker Implantation: Over One Decade and Large Cohort Analysis. Journal of Cardiac Failure. 20, S186-186, 2014.
  26. Yamaguchi T, Tsuchiya T, Nagamoto Y, Miyamoto K, Murotani K, Okishige K and Takahashi N. Long-term results of pulmonary vein antrum isolation in patients with atrial fibrillation: an analysis in regards to substrates and pulmonary vein reconnections. Europace. 16, 511-520, 2014.
  27. Nakajima I, Noda T, Kanzaki H, Wada M, Ishibashi K, Miyamoto K, Okamura H, Aiba T, Kamakura S and Kusano K. Long-term Variation of Left Ventricular Function and Risk Factor for Recurrence of Remodeling after Cardiac Resynchronization Therapy. Journal of Cardiac Failure. 20, S187, 2014.
  28. Anzai T, Nagai T, Sugano Y, Ohara T, Kanzaki H, Asaumi Y, Noguchi T, Kusano K, Yasuda S and Ogawa H. Nationwide Registry of Heart Failure with Preserved Ejection Fraction-JASPER Study. Journal of Cardiac Failure. 20, S141, 2014.
  29. Asaumi Y, Noguchi T, Morita Y, Matsuyama TA, Otsuka F, Fujiwara R, Kanaya T, Nagai T, Higashi M, Kusano K, Anzai T, Ishibashi-Ueda H, Ogawa H and Yasuda S. Non-contrast t1-weighted magnetic resonance imaging at 3.0 tesla in a patient undergoing elective percutaneous coronary intervention. Circulation Journal. 79, 218-220, 2014.
  30. Makita N, Yagihara N, Crotti L, Johnson CN, Beckmann BM, Roh MS, Shigemizu D, Lichtner P, Ishikawa T, Aiba T, Homfray T, Behr ER, Klug D, Denjoy I, Mastantuono E, Theisen D, Tsunoda T, Satake W, Toda T, Nakagawa H, Tsuji Y, Tsuchiya T, Yamamoto H, Miyamoto Y, Endo N, Kimura A, Ozaki K, Motomura H, Suda K, Tanaka T, Schwartz PJ, Meitinger T, Kaab S, Guicheney P, Shimizu W, Bhuiyan ZA, Watanabe H, Chazin WJ and George AL. Novel Calmodulin Mutations Associated With Congenital Arrhythmia Susceptibility. Circulation:Cardiovascular Genetics. 7, 466-U209, 2014.
  31. Yamashita T, Watanabe E, Ikeda T, Shiga T, Kusano K F, Takahashi N, Takahashi T, Nozaki A, Kasao M, Fukatsu T, Kawamura Y, Komatsu T, Matsumoto N, Arakawa T, Sugiura A, Iwao T and Ooie T. Observational study of the effects of dabigatran on gastrointestinal symptoms in patients with non-valvular atrial fibrillation. Journal of Arrhythmia. 30, 478-484, 2014.
  32. Takaya Y, Kusano KF, Nakamura K, Kaji M, Shinya T, Kanazawa S and Ito H. Reduction of myocardial inflammation with steroid is not necessarily associated with improvement in left ventricular function in patients with cardiac sarcoidosis. International journal of cardiology. 176(2), 522-525, 2014.
  33. Lichter JG, Carruth E, Mitchell C, AS Barth., Aiba T, Kass DA, Tomaselli GF, Bridge JH and Sachse FB. Remodeling of the sarcomeric cytoskeleton in cardiac ventricular myocytes during heart failure and after cardiac resynchronization therapy. Journal of Molecular and Cellular Cardiology. 72, 186-195, 2014.
  34. Okamura H. Remote monitoring of cardiovascular implantable electronic devices in Japan. Journal of Arrhythmia. 30, 421-427, 2014.
  35. Akagi S, Nakamura K, Matsubara H, Ohta-Ogo K, Yutani C, Miyaji K, Ogawa A, Kusano K, Oto T, Ishibashi-Ueda H and Ito H. Reverse remodeling of pulmonary arteries by high-dose prostaglandin I2 therapy: A case report. Journal of Cardiology Cases. 9, 173-176, 2014.
  36. Kawakami H, Aiba T, Yamada T, Okayama H, Kazatani Y, Konishi K, Nakajima I, Miyamoto K, Yamada Y, Okamura H, Noda T, Satomi K, Kamakura S, Makita N and Shimizu W. Variable phenotype expression with a frameshift mutation of the cardiac sodium channel gene scn5a. Journal of Arrhythmia. 29, 291-295, 2014.
  37. 廣瀬 紗也子, 草野 研吾. なぜ新規抗凝固薬では出血性合併症が少ないか. 心房細動トータルマネージメント. 47-48, 2014.
  38. 鎌倉 史郎. ブルガダ症候群. 今日の治療指針2014年版. 373-374, 2014.
  39. 相庭 武司. 遺伝性不整脈の薬物療法. Heart View. 18, 80-86, 2014.
  40. 野田 崇, 草野 研吾. 拡張不全の日常診療 Q&A. 2014.
  41. 中島 育太郎, 野田 崇, 石橋 耕平, 山田 優子, 宮本 康二, 岡村 英夫, 里見 和浩, 相庭 武司, 鎌倉 史郎, 草野 研吾, 清水 渉. 虚血性心疾患に伴う心室不整脈に対するデバイス治療. 心電図. 34, 137-143, 2014.
  42. 金山 純二, 野田 崇, 中島 育太郎, 石橋 耕平, 宮本 康二, 岡村 英夫, 相庭 武司, 鎌倉 史郎, 草野 研吾, 安田 聡, 小川 久雄. 原因不明の運動誘発性心室細動を呈した若年発症の洞不全症候群の１例. 心臓. 46s2, 160-166, 2014.
  43. 矢坂 正弘, 草野 研吾, 北島 勲, 平野 照之, 詠田 眞治. 抗凝固療法に伴う頭蓋内出血. Cardio-coagulation. 1, 6-14, 2014.
  44. 宮本 康二, 草野 研吾. 抗凝固療法の人種差. 不整脈治療　update 第3巻. 187-195, 2014.
  45. 相庭 武司. 抗不整脈薬のべからず"集－抗不整脈薬でしてはいけないことー. 心房細動トータルマネージメント. 150-151, 2014.
  46. 草野 研吾. 高齢者・腎不全患者における抗凝固をどうする. 心房細動トータルマネージメント. 65-70, 2014.
  47. 中川 晃志, 永瀬 聡, 和田 匡史, 田中 正道, 西井 伸洋, 寒川 睦子, 湯本 晃久, 向原 直木, 河野 晋久, 中村 一文, 森田 宏, 大江 透, 草野 研吾, 伊藤 浩, 湯本 晃久, 向原 直木, 大江 透. 左室側壁心外膜側に不整脈基質が存在すると考えられたJ波症候群の一例. 臨床心臓電気生理. 37, 127-135, 2014.
  48. 草野 研吾, 峰 隆直, 井上 啓司, 高木 雅彦, 宮本 康二. 使用経験からみる抗凝固療法の新展開―Real Worldにおけるアピキサバンの位置づけー. Pharma Medica. 32, 53-59, 2014.
  49. 石橋 耕平, 草野 研吾. 手術前後の抗凝固薬の使い方. 心房細動トータルマネージメント. 73-74, 2014.
  50. 岡村 英夫, 草野 研吾. 心筋症：診断と治療の進歩 IV. 予後・QOLの改善を目指す治療法の選択 2.心臓再同期療法. 日本内科学雑誌. 10, 387-392, 2014.
  51. 草野 研吾, 宮本 康二, 豊田 一則, 石橋 耕平, 和田 暢, 中島 育太郎, 岡村 英夫, 野田 崇, 相庭 武司, 宮本 恵宏, 鎌倉 史郎. 心原性脳塞栓症への新規抗凝固療法に及ぼす腎機能障害の影響. 循環器病研究の進歩. 5, 46-51, 2014.
  52. 草野 研吾. 心室頻拍を合併しやすい肥大型心筋症の特徴と対策. 心臓. 46, 2-3, 2014.
  53. 和田 揚, 草野 研吾. 心臓突然死の予知と予防法のガイドライン：薬物治療の役割. 医学と薬学. 71, 2057-2063, 2014.
  54. 鎌倉 史郎. 心停止/心室細動の既往のないブルガダ症候群に対するICDの適応は？ CORE JOURNAL循環器. 4, 97-105, 2014.
  55. 草野 研吾. 心拍コントロールのトレンド. Osaka Heart Club. 37, 12-13, 2014.
  56. 草野 研吾. 心房細動に対する低心機能例での抗不整脈薬を用いた洞調律維持療法の現状と再考. 心電図. 33, 449-457, 2014.
  57. 上島 彩子, 草野 研吾. 心房細動の抗凝固療法. Medicina. 51, 1723-1727, 2014.
  58. 奥村 謙, Cappato R, 清水 渉, 高月 誠司, 草野 研吾. 心房細動患者の抗凝固療法における新しい展開-除細動およびカテーテルアブレーション周術期における第Xa因子阻害薬の位置付け-. メディカルトリビューン3月号. 42-44, 2014.
  59. 相庭 武司. 新規経口抗凝固薬使い方の実際. Cardiac-coagulation. 1, 33-40, 2014.
  60. 相庭 武司. 知っておくべきチャネルブロッカーのリスク. 心房細動トータルマネージメント. 139-143, 2014.
  61. 草野 研吾. 妊娠と不整脈. 心臓. 46, 1431-1435, 2014.
  62. 宮本 康二, 草野 研吾. 非ビタミンK阻害経口抗凝固薬開始時の注意点や用量設定について教えてください. ファーマナビゲーター;抗凝固療法編. 2014.
  63. 和田 悠子, 相庭 武司. 無症候性心房細動をいかに診断し治療するか－血栓塞栓症の一次予防を目指して－. Medical Practice. 31, 1621-1626, 2014.
  64. 宮本 康二, 草野 研吾. 5.Question and Answer (2)新規抗凝固薬の注意点や用量設定について. ファーマナビゲーター. 2014.
  65. 鎌倉 令, 草野 研吾. Brugada症候群とはどんな疾患か？その頻度は？. 不整脈クリニカルクエスチョン. 2014.
  66. 草野 研吾. Short-coupled variant of torsade de pointesの1例. 心臓. 2014.
  67. 松浦 秀夫, 棚橋 紀夫, 草野 研吾. NOAC (Novel Oral Anticoaguant)時代の脳卒中の予防・治療. 臨床高血圧. 2014.
  68. 山下 武志, 清水 渉, 池田 隆徳, 高橋 尚彦, 庭野 慎一, 奥山 裕司, 草野 研吾. NOAC適正使用をいかに実践すべきか？―発売からのアピキサバンの使用経験から考えるー. 日経メディカル555. 79-82, 2014.
  69. 金山 純二, 草野 研吾. QT延長症候群、QT短縮症候群とTorsade de pointes. 月刊レジデント. 3, 91-100, 2014.
  70. 草野 研吾. RE-LY試験サブグループ解析。「心房細動患者における腎機能別のワルファリンに対するダビガトランの有効性および安全性」. Thrombosis Scope. 8, 7-8, 2014.

2013年　研究業績

  1. Takigawa M, Kiso K, Noda T, Kurita T, Yamada Y, Okamura H, Satomi K, Suyama K, Aihara N, Nanasato M, Hirayama H, Kamakura S, Shimizu W, and and Ishida Y. Usefulness of scintigraphy to predict electrical storms in severe idiopathic dilated cardiomyopathy. ANNALS OF NUCLEAR MEDICINE. 27, 407-415, 2013.
  2. Noda Y, Miyoshi T, Oe H, Ohno Y, Nakamura K, Toh N, Kohno K, Morita H, Kusano K, and and Ito H. Alogliptin ameliorates postprandial lipemia and postprandial endothelial dysfunction in non-diabetic subjects: a preliminary report. Cardiovasc Diabetol. 12, 8, 2013.
  3. Miura A, Akagi S, Nakamura K, Ohta-Ogo K, Hashimoto K, Nagase S, Kohno K, Kusano K, Ogawa A, Matsubara H, Toyooka S, OtoT, Ohtsuka A, Ohe T, and and Ito H. Different sizes of centrilobular ground-glass opacities in chest high-resolution computed tomography of patients with pulmonary veno-occlusive disease and patients with pulmonary capillary hemangiomatosis. Cardiovasc Pathol. 22, 287-93, 2013.
  4. Osawa K, Miyoshi T, Sato S, Akagi N, Morimitsu Y, Nakamura K, Kohno K, Kusano K, Kanazawa S, and and Ito H. Safety and efficacy of a bolus injection of landiolol hydrochloride as a premedication for multidetector-row computed tomography coronary angiography. Circ J. 77, 146-152, 2013.
  5. Takaya Y, Noda T, Nakajima I, Yamada Y, Miyamoto K, Okamura H, Satomi K, Aiba T, Kusano KF, Kanzaki H, Anzai T, Ishihara M, Yasuda S, Ogawa H, Kamakura S, and and Shimizu W. Electrocardiographic predictors of response to cardiac resynchronization therapy in patients with intraventricular conduction delay. Circ J. 78, 71-77, 2013.
  6. Yoshikawa WS, Nakamura K, Miura D, Shimizu J, Hashimoto K, Kataoka N, Toyota H, Okuyama H, Miyoshi T, Morita H, Kusano KF, Mtsuo T, Takaki M, Kajiya F, Yagi N, Ohe T, and and Ito H. Increased passive stiffness of cardiomyocytes in the transverse direction and residual actin and myosin cross-bridge formation in hypertrophoid rat hearts induced by chronic beta-adrenergic stimulation. . Circ J. 77, 741-748, 2013.
  7. Kamakura S. Necessity of Face-to-Face Encounters With Recipients of Cardiovascular Implantable Electronic Devices With Remote Monitoring. CIRCULATION JOURNAL. 77, 2691-2693, 2013.
  8. Kusano KF. Fragmented QRS Wave as a Marker of Cardiac Events in Various Cardiac Diseases. CIRCULATION JOURNAL. 77, 2873-2874, 2013.
  9. Miyoshi T, Kamiya CA, Katsuragi S, UedaH, Kobayashi Y, Horiuchi C, Yamanaka K, Neki R, Yoshimatsu J, Ikeda T, Yamada Y, Okamura H, Noda T, and and Shimizu W. Safety and Efficacy of Implantable Cardioverter-Defibrillator During Pregnancy and After Delivery. CIRCULATION JOURNAL. 77, 1166-1170, 2013.
  10. Nagai R, Kinugawa K, Inoue H, Atarashi H, Seino Y, Yamashita T, Shimizu W, Aiba T, Kitakaze M, Sakamoto A, Ikeda T, Imai Y, Daimon T, Fujino K, Nagano T, Okamura T, and and Hori M. Urgent Management of Rapid Heart Rate in Patients With Atrial Fibrillation/Flutter and Left Ventricular Dysfunction - Comparison of the Ultra-Short-Acting beta 1-Selective Blocker Landiolol With Digoxin (J-Land Study). CIRCULATION JOURNAL. 77, 908-916, 2013.
  11. Duchatelet S, Crotti L, Peat RA, Denjoy I, Itoh H, Berthet M, Ohno S, Fressart V, Monti MC, Crocamo C, Pedrazzini M, Dagradi F, Vicentini A, Klug D, Brink PA, Goosen A, Swan H, Toivonen L, Lahtinen AM, Kontula K, Shimizu W, Horie M, George AL, Tregouet DA, Guicheney P, and and Schwartz PJ. Identification of a KCNQ1 Polymorphism Acting as a Protective Modifier Against Arrhythmic Risk in Long-QT Syndrome. CIRCULATION-CARDIOVASCULAR GENETICS. 6, 354-361, 2013.
  12. Nosaka K, Nakamura K, Kusano K, Toh N, Tada T, Miyoshi T, Doi M, Kohno K, Morita H, and and Ito H. Serum cystatin C as a biomarker of cardiac diastolic dysfunction in patients with cardiac disease and preserved ejection fraction. Congest Heart Fail. 19, E35-E39, 2013.
  13. Iwakami N, Aiba T, Kamakura S, Takaki H, Nakajima I, Miyamoto K, Okamura H, Noda T, Shimizu W, and and Sugimachi M. Noninvasive evaluation of benign or malignant early repolarization pattern using high resolution magnetocardiography. EUROPEAN HEART JOURNAL. 34, 1034, 2013.
  14. Kimura K, Takaki H, Yamada Y, Noda T, Satomi K, Aiba T, Kamakura S, Yasuda S, Shimizu W, and and Sugimachi M. Magnetocardiographic analysis predicts future lethal arrhythmic events in patients with arrhythmogenic right ventricular cardiomyopathy. EUROPEAN HEART JOURNAL. 34, 912, 2013.
  15. Kokubo Y, Watanabe M, Shimizu W, Kamakura S, Kada A, Kawanishi K, and and Miyamoto Y. Impact of smoking and excessive drinking on the risk of incident atrial fibrillation in the Suita study: an urban cohort study. EUROPEAN HEART JOURNAL. 34, 954, 2013.
  16. Kusano KK, Takaya YT, Miyoshi AM, Morimoto SM, and and Kamakura SK. Isolated type of cardiac sarcoidosis: its prevalence and clinical characteristics. EUROPEAN HEART JOURNAL. 34, 782-783, 2013.
  17. Nakajima I, Noda T, Okamura H, Aiba T, Anzai T, Ishihara M, Yasuda S, Ogawa H, Kamakura S, and and Shimizu W. High value of right ventricular to left ventricular interlead electrical delay during right ventricular pacing predict favorable response in patients with cardiac resynchronization therapy. EUROPEAN HEART JOURNAL. 34, 580, 2013.
  18. Nakashima T, Takaki H, Usami S, Yamada Y, Okamura H, Aiba T, Yasuda S, Kamakura S, Shimizu W, and and Sugimachi M. Multi-directional ventricular conduction on magnetocardiography predicts poor prognosis after CRT implantation. EUROPEAN HEART JOURNAL. 34, 347, 2013.
  19. Yoshinaga M, Kucho Y, Sarantuya J, Ninomiya Y, Horigome H, Ushinohama H, and and Shimizu W. Genetic characteristics of children and adolescents with long QT syndrome diagnosed by school-based electrocardiographic screening programs. EUROPEAN HEART JOURNAL. 34, 421-422, 2013.
  20. Nakashima K, Kusakawa I, Yamamoto T, Hirabayashi S , Hosoya R, Shimizu W and Sumitomo N. A left ventricular noncompaction in a patient with long QT syndrome caused by a KCNQ1 mutation: a case report. HEART AND VESSELS. 28, 126-129, 2013.
  21. Iguchi K, Noda T, Kamakura S, and and Shimizu W. Beneficial effects of cilostazol in a patient with recurrent ventricular fibrillation associated with early repolarization syndrome. HEART RHYTHM. 10, 604-606, 2013.
  22. Kawata H, Morita H, Yamada Y, Noda T, Satomi K, Aiba T, Isobe M, Nagase S, Nakamura K, Kusano K, Fukushima Ito, H, Kamakura S, and and Shimizu W. Prognostic significance of early repolarization in inferolateral leads in Brugada patients with documented ventricular fibrillation: a novel risk factor for Brugada syndrome with ventricular fibrillation. Heart Rhythm. 10, 1161-1168, 2013.
  23. Mathias A, Moss AJ, Lopes CM, Barsheshet A, McNitt S, Zareba W, Robinson JL, Locati EH, Ackerman MJ, Benhorin J, Kaufman ES, Platonov PG, QiM, Shimizu W, Towbin JA, Vincent GM, Wilde AM, Zhang L, and and Goldenberg I. Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome. HEART RHYTHM. 10, 720-725, 2013.
  24. Akagi S, Nakamura K, Matsubara H, Kusano KF, Kataoka N, Oto T, Miyaji K, Miura A, Ogawa A, Yoshida M, Ueda-Ishibashi H, Yutani C, and and Ito H. Prostaglandin I-2 induces apoptosis via upregulation of Fas ligand in pulmonary artery smooth muscle cells from patients with idiopathic pulmonary arterial hypertension. INTERNATIONAL JOURNAL OF CARDIOLOGY. 165, 499-505, 2013.
  25. Watanabe H, Ohkubo K, Watanabe I, Matsuyama T, Ishibashi-Ueda H, Yagihara N, Shimizu W, Horie M, Minamino T, and and Makita N. SCN5A mutation associated with ventricular fibrillation, early repolarization, and concealed myocardial abnormalities. INTERNATIONAL JOURNAL OF CARDIOLOGY. 165, E21-E23, 2013.
  26. Kusano KF. Brugada syndrome :Recent understanding of pathophysiological mechanism and treament. J Arrhythmia. 29, 77-82, 2013.
  27. Takaya Y, Taniguchi M, Akagi T, Nobusada S, Kusano K, Ito H, and and Sano S. Long-term effects of transcatheter closure of atrial septal defect on cardiac remodeling and exercise capacity in patients older than 40 years with a reduction in cardiopulmonary function. J Interv Cardiol. 26, 195-199, 2013.
  28. Kamakura S. Epidemiology of Brugada syndrome in Japan and rest of the world. Journal of Arrhythmia. 29, 52-55, 2013.
  29. Kamakura S. Two decades of progress in the understanding of Brugada syndrome. Journal of Arrhythmia. 29, 51, 2013.
  30. Sumikura H, Homma A, Ohnuma K, Taenaka Y, Takewa Y, Mukaibayashi H, Katano K, and and Tatsumi E. Development and evaluation of endurance test system for ventricular assist devices. JOURNAL OF ARTIFICIAL ORGANS. 16, 138-148, 2013.
  31. Kusano KF. Effect of corticosteroid on arrhythmic events in patients with cardiac sarcoidosis. JOURNAL OF CARDIOLOGY. 62, 326-327, 2013.
  32. Okamura H, Yasuda S, Sato S, Ogawa K, Nakajima I, Noda T, Shimahara Y, Hayashi T, Onishi Y, Kobayashi J, Kamakura S, Ogawa H, and and Shimizu W. Initial experience using Excimer laser for the extraction of chronically implanted pacemaker and implantable cardioverter defibrillator leads in Japanese patients. JOURNAL OF CARDIOLOGY. 62, 195-200, 2013.
  33. Doi A, Satomi K, Makimoto H, Yokoyama T, Yamada Y, Okamura H, Noda T, Aiba T, Aihara N, Yasuda S, Ogawa H, Kamakura S, and and Shimizu W. Efficacy of Additional Radiofrequency Applications for Spontaneous Dissociated Pulmonary Vein Activity After Pulmonary Vein Isolation in Patients with Paroxysmal Atrial Fibrillation. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 24, 894-901, 2013.
  34. Makimoto H, Satomi K, Wada M, and and Shimizu W. Double Tachycardia After Slow Pathway Ablation for Atrioventricular Nodal Tachycardia: What Is the Mechanism?. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY. 24, 233-236, 2013.
  35. Kamakura T, Kawata H, Nakajima I, Yamada Y, Miyamoto K, Okamura H, Noda T, Satomi K, Aiba T, Takaki H, Aihara N, Kamakura S, Kimura T, and and Shimizu W. Significance of Non-Type 1 Anterior Early Repolarization in Patients With Inferolateral Early Repolarization Syndrome. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 62, 1610-1618, 2013.
  36. Villafane J, Atallah J, Gollob MH, Maury P, Wolpert C, Gebauer R, Watanabe H, Horie M, Anttonen O, Kannankeril P, Faulknier B, Bleiz J, Makiyama T, Shimizu W, Hamilton RM, and and Young ML. Long-Term Follow-Up of a Pediatric Cohort With Short QT Syndrome. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY. 61, 1183-1191, 2013.
  37. Bezzina CR, Barc J, Mizusawa Y, Remme CA, Gourraud JB, Simonet F, Verkerk AO, Schwartz PJ, Crotti L, Dagradi F, Guicheney P, Fressart V, Leenhardt A, Antzelevitch C, Bartkowiak S, Schulze-Bahr E, Zumhagen S, Behr ER, Bastiaenen R, Tfelt-Hansen J, Olesen MS, Kaab S, Beckmann BM, Weeke P, Watanabe H, Endo N, Minamino T, Horie M, Ohno S, Hasegawa K, Makita N, Nogami A, Shimizu W, Aiba T, Froguel P, Balkau B, Lantieri O, Torchio M, Wiese C, Weber D, Wolswinkel R, Coronel R, Boukens BJ, Bezieau S, Charpentier E, Chatel S, Despres A, Gros F, Kyndt F, Lecointe S, Lindenbaum P, Portero V, Violleau J, Gessler M, Tan HL, Roden DM, Christoffels VM, MarecH Le, Wilde AA, Probst V, Schott JJ, Dina C, and and Redon R. Common variants at SCN5A-SCN10A and HEY2 are associated with Brugada syndrome, a rare disease with high risk of sudden cardiac death. NATURE GENETICS. 45, 1044-1049, 2013.
  38. Kawata H, Satomi K, Yamagata K, and and Kamakura S. Successful Slow Pathway Ablation in a Patient with a Rare Unroofed Type Coronary Sinus. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY. 36, e100-e102, 2013.
  39. Nakano Y, Chayama K, Ochi H, Toshishige M, Hayashida Y, Miki D, Hayes CN, Suzuki H, Tokuyama T, Oda N, Suenari K, Uchimura-Makita Y, Kajihara K, Sairaku A, Motoda C, Fujiwara M, Watanabe Y, Yoshida Y, Ohkubo K, Watanabe I, Nogami A, Hasegawa K, Watanabe H, Endo N, Aiba T, Shimizu W, Ohno S, Horie M, Arihiro K, Tashiro S, Makita N, and and Kihara Y. A Nonsynonymous Polymorphism in Semaphorin 3A as a Risk Factor for Human Unexplained Cardiac Arrest with Documented Ventricular Fibrillation. PLOS GENETICS. 9, 2013.
  40. Nakamura Y, Kusano KF, Nakamura K, Kobayashi K, Hozumi N, Saijo Y, and and Ohe T. A new diagnostic feasibility for cardiomyopathy utilizing acoustic microscopy. World Journal of Cardiovascular Diseases. 3, 22-30, 2013.
  41. 山田 優子, 清水 渉. 【決定版　病棟必携!カラーで診る心血管疾患の画像診断マニュアル　疾患別でみるモダリティの基礎知識とテクニック】　(第1章)心血管疾患の診断に用いられる画像検査の基礎知識 心電図の基礎知識. CIRCULATION Up-to-Date. 8, 8-12, 2013.
  42. 山田 優子, 里見 和浩. 【進化した3Dイメージング(前編) CT・MRIの見かた・撮りかた】 総論. CIRCULATION Up-to-Date. 8, 262-269, 2013.
  43. 相庭 武司. 先輩エキスパートがコツを伝授　処方のポイント　III群抗不整脈薬の使い方. CIRCULATION Up-to-Date. 8, 731-738, 2013.
  44. 岡村 英夫. 【不整脈の非薬物療法】 治す　もう一歩進んだデバイスの植え込みと管理　CRT-PとCRT-D. Heart View. 17, 1130-1134, 2013.
  45. 岡村 英夫, 鎌倉 史郎. 【心筋症up to date】 治す　デバイス治療の適応と課題はなにか. Heart View. 17, 301-308, 2013.
  46. 野田 崇. 【不整脈の非薬物療法】 診る　不整脈デバイス　どう診断し、適応を決めるか. Heart View. 17, 1069-1076, 2013.
  47. 星野 真介, 津田 悦子, 安田 謙二, 阿部 忠朗, 坂口 平馬, 宮崎 文, 岡村 英夫, 里見 和浩, 鎌倉 史郎, 北村 惣一郎. 【川崎病-第37回近畿川崎病研究会-】 Implantable Cardioverter Defibrillator(植え込み型除細動器)治療を施行した川崎病既往3症例. Progress in Medicine. 33, 1488-1494, 2013.
  48. 相庭 武司. 集中治療におけるアミオダロン注の位置づけ VT stormとアミオダロン注射剤から錠剤への移行. Progress in Medicine. 33, 784-787, 2013.
  49. 宮本 康二, 清水 渉. 心房細動の発症予防においてβ遮断薬が効く症例とは？ β遮断薬を臨床で活かす！ 88-90, 2013.
  50. 宮本 康二, 草野 研吾. 【抗凝固療法のNew Trend】 ワルファリン、NOAC(新規抗凝固薬)のメリット・デメリット. クリニシアン. 60, 1042-1047, 2013.
  51. 中島 育太郎. 【心房細動に困っている!Afのあるときの乗り切りかたQ&A】 心房細動の乗り切りかたQ&A　不整脈発作が疑われて入院したWPW症候群の患者を担当することになりました。何に注意すればいい? ナーシング. 33, 74-75, 2013.
  52. 佐藤俊輔, 小林 順二郎, 岡村 英夫. 【新人ナースお助け号!術式別イラストで見える・わかる・動ける　よく出会う心臓手術の術後ケア】 術式別解説　デバイス植込み術. ハートナーシング. 26, 587-589, 2013.
  53. 相庭 武司, 清水 渉. 【イオンチャネル病のすべて】 QT延長症候群　遺伝子タイプ別の病態・予後・治療方法　多施設登録研究からみた日本人のエビデンス. 医学のあゆみ. 245, 766-772, 2013.
  54. 草野 研吾. 【心臓サルコイドーシス診療の最前線-早期診断と適切な治療をめざして】 心臓サルコイドーシスの非薬物治療　心サルコイドーシスにおける不整脈への対応. 医学のあゆみ. 247, 177-181, 2013.
  55. 宮本 康二. 【あなたなら、どう動く?不整脈診療Q&A-しのぐ・備える・攻める-】 速やかに動く　心房細動に出会ったとき. 救急・集中治療. 25, 538-545, 2013.
  56. 野田 崇. 【救急医療に必要な不整脈診療の実際】 知っておくと役立つ不整脈の知識　デバイス植込み例の終末期における注意点. 救急医学. 37, 230-235, 2013.
  57. 相庭 武司. 【致死性不整脈診療の最前線】 致死性不整脈診療　後天性QT延長症候群. 最新医学. 68, 1570-1578, 2013.
  58. 桂木 真司, 山田 優子, 清水 渉, 吉松 淳. 【事例から学ぶ妊産婦死亡の予防対策】 QT延長症候群. 周産期医学. 43, 89-94, 2013.
  59. 草野 研吾. 【心肺連関】 循環器治療薬の肺への影響　アミオダロンを中心に. 循環器内科. 74, 61-65, 2013.
  60. 草野 研吾. リバーロキサバンはどんな薬か. 心原性脳塞栓症と経口抗凝固薬―新規抗凝固薬の選び方・使い方. 53-63, 2013.
  61. 宮本 康二, 安岡 千枝, 谷岡 芳人, 土谷 健, 清水 渉. Andersen-Tawil症候群の心室性不整脈に対してフレカイニドが有効であった1例. 心臓. 45, 184-188, 2013.
  62. 宮本 康二, 清水 渉. 【反射性(神経調節性)失神】 Brugada症候群と失神(神経調節性失神の意義). 心臓. 45, 1370-1373, 2013.
  63. 草野 研吾. 磯貝論文に対するEditorial Comment　若年失神例、てんかん例に対する心電図記録の重要性. 心臓. 45, 1130-1131, 2013.
  64. 中川 晃志, 永瀬 聡, 和田 匡史, 田中 正道, 西井 伸洋, 渡邊 敦之, 中村 一文, 森田 宏, 河野 晋久, 草野 研吾, 大江 透, 伊藤 浩. 右室単発早期刺激により明瞭なcoved型そしてsaddleback型心電図が得られたBrugada症候群の1例. 心臓. 45, 143-148, 2013.
  65. 里見 和浩, 岡松 秀治, 和田 暢, 井口 公平, 小林 貴, 船迫 宴福, 川上 大志, 大塚 陽介, 中島 育太郎, 野田 崇, 宮本 康二, 山田 優子, 岡村 英夫, 相庭 武司, 鎌倉 史郎, 清水 渉. 特殊心筋疾患に合併する致死性不整脈に対するカテーテルアブレーション治療戦略　催不整脈性右室心筋症および心サルコイドーシスを中心に. 心電図. 33, 263-269, 2013.
  66. 岡村 英夫. 【3章】疾患の基礎理解　4不整脈. 新版CCU看護マニュアル. 2013.
  67. 鎌倉 史郎. 危険のない心房性期外収縮や心室性期外収縮の多発例で抗凝固薬が不要な理由. 日本医事新報. 56-57, 2013.
  68. 鎌倉 史郎. 【二人三脚　不整脈診療】 Brugada波形. 日本医事新報. 33-39, 2013.
  69. 野田 崇, 清水 渉. 【二人三脚　不整脈診療】 QT延長・短縮. 日本医事新報. 40-45, 2013.
  70. 竹井 大介, 高木 章乃夫, 草野 研吾. 非代償性肝硬変の合併症と予後 肝硬変における心エコー所見とその有用性について. 日本消化器病学会雑誌. 110, A133, 2013.
  71. 清水 渉. 【心房細動-診断・治療の最新動向-】 心房細動と遺伝子異常. 日本臨床. 71, 161-166, 2013.
  72. 峰松一夫, 岡田 靖, 鎌倉 史郎, 植田 初江. 【心臓病と脳卒中】 心臓病と脳卒中　温故知新. 脳と循環. 18, 191-199, 2013.
  73. 岡村 英夫. 動悸・脈の欠帯感. 不整脈概論. 2013.
  74. 草野 研吾. V. 心室頻拍①非持続性心室頻拍. 不整脈概論. 340-347, 2013.
  75. 草野 研吾. 不整脈でも心不全―心房細動、心室性期外収縮. 変貌する心不全診療. 39-43, 2013.
  76. 草野 研吾. 【不整脈の薬物療法管理】 病態に応じた治療のポイント　心不全を合併した心房細動. 薬事. 55, 1297-1302, 2013.
  77. 和田 暢, 里見 和浩, 井口 公平, 岡松 秀治, 小林 貴, 中島 育太郎, 宮本 康二, 山田 優子, 岡村 英夫, 野田 崇, 相庭 武司, 相原直彦, 鎌倉 史郎, 清水 渉. 房室結節リエントリー性頻拍と心房細動のDual Tachycardiaを呈し、上部共通路の存在が示唆された1例. 臨床心臓電気生理. 36, 161-167, 2013.

last updated : 2021/10/01

Site setting